A little over a year ago, I woke up in the middle of the night with an itchy scalp. I didn’t give it much thought, assuming ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients ...

Such symptoms might be due to urticaria, commonly known as hives. Urticaria is a skin condition characterised by red, itchy welts. Although the itchiness might be temporary, the condition can recur, ...

Sanofi and Regeneron’s blockbuster drug Dupixent successfully treated patients with an inflammatory skin disease in a ...

Mental health experts reveal the signs of chronic stress, the unhealthy hormonal changes it can trigger and simple, ...

Results from a confirmatory study show that dupilumab significantly reduces itch in patients with uncontrolled chronic spontaneous urticaria.

Confirming the results of Study A, this second pivotal trial in biologic-naïve patients met primary and key secondary endpoints, showing ...

Eleven months after sustaining a rejection from the FDA for Dupixent to treat chronic spontaneous urticaria (CSU), Sanofi and ...

Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNPCurrent treatment ...

Femtech, or digital solutions centered on women's health and wellness, could help address gaps in the healthcare system.

Following an FDA rejection last year, the partners plan to resubmit their application for approval of Dupixent in chronic ...